2021-02-05 sec-litreleases litigation_release 64 KB 1,333 chars

SEC v. Mark Ahn, No. LR-25024, District of Massachusetts (Feb. 5, 2021) — Press Release

raw: Mark Ahn

Mark Ahn, No. 1:21-cv-10203 (Feb. 5, 2021)

Caption
Securities & Exchange Commission v. Ahn
Source PDF JSON
summary

Mark Ahn, former consultant and board member, committed insider trading in Dimension Therapeutics' securities ahead of an August 2017 merger announcement, facing SEC penalties and parallel criminal charges.

paragraph

The SEC charged Mark Ahn with insider trading in Dimension Therapeutics' securities ahead of an August 2017 merger announcement. Ahn allegedly violated Section 10(b) of the Securities Exchange Act and Rule 10b-5. The SEC seeks penalties, injunctive relief, and an officer-director bar against Ahn.

narrative

The Securities and Exchange Commission charged Mark Ahn, a former consultant and board member of Dimension Therapeutics, Inc., with insider trading in the company's securities ahead of an August 2017 merger announcement. Ahn is accused of violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 by trading on non-public information. The SEC's complaint, filed in federal district court in Massachusetts, seeks penalties, injunctive relief, and a bar from serving as an officer or director of any SEC-reporting company. A parallel criminal case was announced by the U.S. Attorney's Office for the District of Massachusetts. The SEC's case is being handled by the Boston Regional Office with assistance from the FBI and the Financial Industry Regulatory Authority. No specific monetary amounts were disclosed in the complaint. The SEC's action is part of a collaborative effort with other regulatory and law enforcement agencies.

Enriched metadata

Scheme
insider-trading (100%)
Court
District of Massachusetts
Case No.
1:21-cv-10203
Entity
Mark Ahn
Classified insider-trading(confidence 100%). EDGAR detection: forms 4/3/5/144· recall 81% / precision 19%. detection rule →
Statutes
Section 10(b) of the Securities Exchange ActRule 10b-5
Parties
Securities & Exchange CommissionMark J Ahn
Keywords
ahnsecurities exchangeexchange commissionsecuritiesmarkexchangesecinsider tradingfebruary securitiesattorney's massachusettscommissionfebruarymassachusettsinsidertrading

Exhibits & Attached Documents (1)

Extracted insights

Entities 15
  • person antifraud provisions
  • court complaint in federal district court in massachusetts
  • company dimension therapeutics, inc.
  • scheme_term insider trading
  • company in the securities of dimension therapeutics, inc.
  • person mark ahn
  • scheme_term mark ahn with insider trading
  • company mark ahn with insider trading in the securities of dimension therapeutics, inc.
  • location massachusetts
  • company massachusetts-based pharmaceutical company
  • location oregon
  • person oregon resident
  • agency sec's complaint
  • agency Securities and Exchange Commission
  • company securities of dimension therapeutics, inc.
Triples 46
  • SEC charged Mark Ahn with insider trading
  • Mark Ahn violating the antifraud provis
  • Securities and Exchange Commission charged Mark Ahn with insider trading in the securities of Dimension Therapeutics, Inc.
  • Mark Ahn violated the antifraud provisions
  • SEC filed complaint in federal district court in Massachusetts
  • Mark Ahn is former consultant and board member
  • Dimension Therapeutics, Inc. is Massachusetts-based pharmaceutical company
  • SEC announced merger in August 2017
  • Securities and Exchange Commission charged Mark Ahn with insider trading
  • Mark Ahn is former consultant and board member
  • Mark Ahn is Oregon resident
  • Mark Ahn traded securities of Dimension Therapeutics, Inc.
  • Dimension Therapeutics, Inc. is Massachusetts-based pharmaceutical company
  • SEC filed complaint in federal district court in Massachusetts
  • Ahn violated antifraud provisions
  • Securities and Exchange Commission charged Mark Ahn with insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission charged Mark Ahn with insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission charged Mark Ahn with insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission charges Mark Ahn
  • Securities and Exchange Commission charged Mark Ahn
  • Mark Ahn with insider trading in the securities of Dimension Therapeutics, Inc.
  • Mark Ahn is Former Consultant and Board Member
  • Mark Ahn is Oregon resident
  • Dimension Therapeutics, Inc. is Massachusetts-based pharmaceutical company
  • Securities and Exchange Commission filed complaint
  • Mark Ahn with violating the antifraud provis
  • Securities and Exchange Commission charged Mark Ahn with insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Mark Ahn charged with insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission charges Mark Ahn
  • Securities and Exchange Commission charges Mark Ahn with insider trading
  • Mark Ahn charged with insider trading
  • Mark Ahn charged with violating the antifraud provis
  • Securities and Exchange Commission filed complaint
  • Mark Ahn resides in Oregon
  • Dimension Therapeutics, Inc. based in Massachusetts
  • Securities and Exchange Commission filed Litigation Release No. 25024
  • Securities and Exchange Commission filed February 5, 2021
  • Securities and Exchange Commission charged Mark Ahn with insider trading in the securities of Dimension Therapeutics, Inc.
  • SEC's complaint charges Mark Ahn with violating the antifraud provisions
  • Mark Ahn was former consultant and board member
  • Securities and Exchange Commission v. Mark Ahn filed case No. 1:21-cv-10203 in the District of Massachusetts on February 5, 2021
  • SEC charged Mark Ahn
  • Mark Ahn violating the antifraud provis
  • SEC charged Mark Ahn with insider trading
  • SEC filed complaint in federal district court in Massachusetts
  • Mark Ahn violating antifraud provis
PDF (from attached: complaint)
Plaintiff, the United States Securities and Exchange Commission (the “Commission”), · Source
Text layers
Extracted body text (1,333c) 
Securities and Exchange Commission SEC Charges Former Consultant and Board Member with Insider Trading Litigation Release No. 25024 / February 5, 2021 Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021) On February 5, 2021, the Securities and Exchange Commission charged Oregon resident Mark Ahn with insider trading in the securities of Massachusetts-based pharmaceutical company Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement. The SEC's complaint, filed in federal district court in Massachusetts, charges Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks penalties, injunctive relief, and an order barring Ahn from serving as an officer or director of any SEC-reporting company. In a parallel action, the U.S. Attorney's Office for the District of Massachusetts announced criminal charges against Ahn. The SEC's case is being handled by Asita Obeyesekere, Nita Klunder, Xinyue Angela Lin, Sofia Hussain, Al Day, and Paul G. Block of the Boston Regional Office. The SEC appreciates the assistance of the U.S. Attorney's Office for the District of Massachusetts, the Federal Bureau of Investigation, and the Financial Industry Regulatory Authority. SEC Complaint
OCR text (1,333c · html-text · 99% conf) 
Securities and Exchange Commission SEC Charges Former Consultant and Board Member with Insider Trading Litigation Release No. 25024 / February 5, 2021 Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021) On February 5, 2021, the Securities and Exchange Commission charged Oregon resident Mark Ahn with insider trading in the securities of Massachusetts-based pharmaceutical company Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement. The SEC's complaint, filed in federal district court in Massachusetts, charges Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks penalties, injunctive relief, and an order barring Ahn from serving as an officer or director of any SEC-reporting company. In a parallel action, the U.S. Attorney's Office for the District of Massachusetts announced criminal charges against Ahn. The SEC's case is being handled by Asita Obeyesekere, Nita Klunder, Xinyue Angela Lin, Sofia Hussain, Al Day, and Paul G. Block of the Boston Regional Office. The SEC appreciates the assistance of the U.S. Attorney's Office for the District of Massachusetts, the Federal Bureau of Investigation, and the Financial Industry Regulatory Authority. SEC Complaint

Related documents (1)